EZH2 and neoplasm: EZH2, an important gene in cell cycle regulation, was associated with an aggressive tumour phenotype, with high levels of EZH2 correlating with reduced 5-year survival (EZH2-negative 71% patients disease free; EZH2-positive, only 48%) [41].